🎁 Black Friday: up to 50% off of annual plans
AmCad BioMed Corporation (TPEX:4188)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.05
-1.10 (-9.05%)
Nov 20, 2026, 1:30 PM CST

AmCad BioMed Statistics

Total Valuation

AmCad BioMed has a market cap or net worth of TWD 699.83 million. The enterprise value is 447.73 million.

Market Cap699.83M
Enterprise Value 447.73M

Important Dates

The next estimated earnings date is Friday, February 26, 2027.

Earnings Date Feb 26, 2027
Ex-Dividend Date n/a

Share Statistics

AmCad BioMed has 63.33 million shares outstanding. The number of shares has increased by 0.09% in one year.

Current Share Class 63.33M
Shares Outstanding 63.33M
Shares Change (YoY) +0.09%
Shares Change (QoQ) -2.62%
Owned by Insiders (%) 6.64%
Owned by Institutions (%) 0.95%
Float 31.63M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 26.75
PB Ratio 1.36
P/TBV Ratio 1.52
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 17.11
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 16.57, with a Debt / Equity ratio of 0.02.

Current Ratio 16.57
Quick Ratio 15.36
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -345.68

Financial Efficiency

Return on equity (ROE) is -12.09% and return on invested capital (ROIC) is -9.36%.

Return on Equity (ROE) -12.09%
Return on Assets (ROA) -9.05%
Return on Invested Capital (ROIC) -9.36%
Return on Capital Employed (ROCE) -15.34%
Weighted Average Cost of Capital (WACC) 6.17%
Revenue Per Employee 769,471
Profits Per Employee -1.64M
Employee Count 34
Asset Turnover 0.04
Inventory Turnover 0.74

Taxes

In the past 12 months, AmCad BioMed has paid 12,000 in taxes.

Income Tax 12,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.30% in the last 52 weeks. The beta is 0.36, so AmCad BioMed's price volatility has been lower than the market average.

Beta (5Y) 0.36
52-Week Price Change -27.30%
50-Day Moving Average 14.28
200-Day Moving Average 12.49
Relative Strength Index (RSI) 28.79
Average Volume (20 Days) 396,634

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, AmCad BioMed had revenue of TWD 26.16 million and -55.64 million in losses. Loss per share was -0.88.

Revenue26.16M
Gross Profit 5.87M
Operating Income -90.57M
Pretax Income -71.99M
Net Income -55.64M
EBITDA -79.89M
EBIT -90.57M
Loss Per Share -0.88
Full Income Statement

Balance Sheet

The company has 331.64 million in cash and 12.18 million in debt, with a net cash position of 319.46 million or 5.04 per share.

Cash & Cash Equivalents 331.64M
Total Debt 12.18M
Net Cash 319.46M
Net Cash Per Share 5.04
Equity (Book Value) 582.78M
Book Value Per Share 8.36
Working Capital 341.00M
Full Balance Sheet

Cash Flow

Operating Cash Flow -51.98M
Capital Expenditures n/a
Depreciation & Amortization 10.67M
Net Borrowing -4.69M
Free Cash Flow -51.98M
FCF Per Share -0.82
Full Cash Flow Statement

Margins

Gross margin is 22.42%, with operating and profit margins of -346.18% and -212.67%.

Gross Margin 22.42%
Operating Margin -346.18%
Pretax Margin -275.18%
Profit Margin -212.67%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AmCad BioMed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -0.09%
Shareholder Yield -0.09%
Earnings Yield -7.96%
FCF Yield -7.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2